sch 34826 has been researched along with spirapril in 1 studies
Studies (sch 34826) | Trials (sch 34826) | Recent Studies (post-2010) (sch 34826) | Studies (spirapril) | Trials (spirapril) | Recent Studies (post-2010) (spirapril) |
---|---|---|---|---|---|
31 | 2 | 0 | 123 | 59 | 3 |
Protein | Taxonomy | sch 34826 (IC50) | spirapril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.067 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forlani, A; Monopoli, A; Ongini, E | 1 |
1 other study(ies) available for sch 34826 and spirapril
Article | Year |
---|---|
Chronic inhibition of neutral endopeptidase reduces left ventricular hypertrophy without changing blood pressure in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Dioxolanes; Dipeptides; Enalapril; Hypertension; Methionine; Myocardium; Neprilysin; Rats; Rats, Inbred SHR | 1991 |